Compare LyondellBasell Industries NV (LYB) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
LyondellBasell Industries NV vs McKesson Corporation — how do they compare? LyondellBasell Industries NV trades at $61.25 (market cap $19.60B), while McKesson Corporation trades at $832.45 (market cap $97.35B). The key difference: McKesson Corporation is far larger — about 5× LyondellBasell Industries NV's market cap, and LyondellBasell Industries NV pays the higher dividend (6.78%). Which is the better fit depends on your goals.
| LYB | MCK | |
|---|---|---|
Market Cap | $19.60B | $97.35B |
Sector | Basic Materials | Health |
52-Week High | $82.38 | $995.69 |
52-Week Low | $42.28 | $659.01 |
Enterprise Value | $31.22B | $101.98B |
Dividend Yield | 6.78% | 0.39% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About LyondellBasell Industries NV
LyondellBasell Industries NV is a petrochemical producer with operations in the U.S. and Europe. It operates in six segments: Olefins and Polyolefins-Americas (O&P-Americas), Olefins and Polyolefins-Europe, Asia, International (O&P-EAI), Intermediates and Derivatives (I&D), Advanced Polymer Solutions (APS), Refining and Technology. The company is a major producer of polyethylene, the world's largest producer of polypropylene, and the second- largest producer of propylene oxide. Its chemicals are used in various consumer and industrial end products. Substantially, all of the company's revenue is derived from product sales.
Read more on LYB →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
